RESDSRARE EARTH SDS LIBRARY
Documents › All PDFs

Gadoteridol | SDS | CAS 120066-54-8 | MedChemExpress | English

Original MedChemExpress safety data sheet for Gadoteridol. Original PDF retained without modification. Source collected on 2026-09-13.

Publisher
MedChemExpress
Document type
SDS
Material
Gadoteridol
CAS
120066-54-8
Product code
Not stated
Language
English
Revision
Not stated
Region
Not stated
Pages
6
Open original PDF

View all PDF documents · Sitemap

GdOrganic / coordination complex
Why this document matches

Exact matching uses the declared substance composition; trace impurities are not excluded.

C · Composition · Page 1
Formula: C17H28GdN4O7
H · Composition · Page 1
Formula: C17H28GdN4O7
Gd · Composition · Page 1
Formula: C17H28GdN4O7
N · Composition · Page 1
Formula: C17H28GdN4O7
O · Composition · Page 1
Formula: C17H28GdN4O7

Other documented elements: C, H, N, O

Source and record details

Original record title
Gadoteridol — Safety Data Sheet — MedChemExpress
Added to RESDS
2026-09-13T12:49:04.000Z
Record updated
2026-09-13T13:35:03.233Z
Original SDS revision
Not stated
Original PDF SHA-256
168c476c2560cc87bc5743ebb32be3619ebfbd55af220cb9cfddcc24084ed64a

Original publisher/source document

Record dates describe this website, not the supplier’s revision date. Check the original PDF and obtain the applicable current version from its publisher.

Related indexes and classification basis

Report a correction or request a document update

Report incorrect metadata, extraction errors, a newer supplier version or a rights concern. Reports are stored for the site operator to review; a submission does not immediately change a published SDS.

Your report and optional email are stored privately for handling this request. They are not published on this site. Do not include sensitive information.

Full document text

6 pages · Original document language

Download TXTBack to PDF ↑

Text extracted from the original PDF. Page order and original wording are preserved; tables and symbols may differ from the PDF layout. Check the original PDF for safety-critical details.

Page 1

Safety Data Sheet Inhibitors

Revision Date: Nov.-6-2023 • Print Date: Oct.-15-2025

1. PRODUCT AND COMPANY IDENTIFICATION Screening

1.1 Product identifier

Product name : Gadoteridol Libraries Catalog No. : HY-B0933 CAS No. : 120066-54-8 •

1.2 Relevant identified uses of the substance or mixture and uses advised against

Identified uses : Laboratory chemicals, manufacture of substances. Proteins 1.3 Details of the supplier of the safety data sheet

Company: MedChemExpress USA

Tel: 609-228-6898

Fax: 609-228-5909

E-mail: sales@medchemexpress.com

1.4 Emergency telephone number

Emergency Phone #: 609-228-6898

2. HAZARDS IDENTIFICATION

2.1 Classification of the substance or mixture

Not a hazardous substance or mixture.

2.2 GHS Label elements, including precautionary statements

Not a hazardous substance or mixture.

2.3 Other hazards

None.

3. COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substances

Synonyms: SQ-32692; Gd-HP-DO3A

Formula: C17H28GdN4O7

Molecular Weight: 557.68

CAS No. : 120066-54-8

4. FIRST AID MEASURES

4.1 Description of first aid measures

Eye contact

Remove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids

with fingers to ensure adequate flushing. Promptly call a physician.

Skin contact

Page 1 of 6 www.MedChemExpress.com

Page 2

Rinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.

Inhalation

Immediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-

to-mouth resuscitation.

Ingestion

Wash out mouth with water; Do NOT induce vomiting; call a physician.

4.2 Most important symptoms and effects, both acute and delayed

The most important known symptoms and effects are described in the labelling (see section 2.2).

4.3 Indication of any immediate medical attention and special treatment needed

Treat symptomatically.

5. FIRE FIGHTING MEASURES

5.1 Extinguishing media

Suitable extinguishing media

Use water spray, dry chemical, foam, and carbon dioxide fire extinguisher.

5.2 Special hazards arising from the substance or mixture

During combustion, may emit irritant fumes.

5.3 Advice for firefighters

Wear self-contained breathing apparatus and protective clothing.

6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures

Use full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate

personnel to safe areas.

Refer to protective measures listed in sections 8.

6.2 Environmental precautions

Try to prevent further leakage or spillage. Keep the product away from drains or water courses.

6.3 Methods and materials for containment and cleaning up

Absorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and

equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.

6.4 Reference to other sections

For disposal see section 13.

7. HANDLING AND STORAGE

7.1 Precautions for safe handling

Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust

ventilation.

7.2 Conditions for safe storage, including any incompatibilities

Keep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.

Recommended storage temperature: Powder -20°C 3 years

4°C 2 years

Page 2 of 6 www.MedChemExpress.com

Page 3

In solvent -80°C 6 months

-20°C 1 month Shipping at room temperature if less than 2 weeks.

7.3 Specific end use(s)

No data available.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters

Components with workplace control parameters

This product contains no substances with occupational exposure limit values.

8.2 Exposure controls

Engineering controls

Ensure adequate ventilation. Provide accessible safety shower and eye wash station.

Personal protective equipment

Eye protection Safety goggles with side-shields.

Hand protection Protective gloves.

Skin and body protection Impervious clothing.

Respiratory protection Suitable respirator.

Environmental exposure controls Keep the product away from drains, water courses or the soil. Clean

spillages in a safe way as soon as possible.

9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

Appearance Solid

Odor No data available

Odor threshold No data available

pH No data available

Melting/freezing point 188-193°C

Boiling point/range No data available

Flash point No data available

Evaporation rate No data available

Flammability (solid, gas) No data available

Upper/lower flammability or explosive limits No data available

Vapor pressure No data available

Vapor density No data available

Relative density No data available

Water Solubility No data available

Partition coefficient No data available

Auto-ignition temperature No data available

Decomposition temperature No data available

Viscosity No data available

Explosive properties No data available

Page 3 of 6 www.MedChemExpress.com

Page 4

Oxidizing properties No data available

9.2 Other safety information

No data available.

10. STABILITY AND REACTIVITY

10.1 Reactivity

No data available.

10.2 Chemical stability

Stable under recommended storage conditions.

10.3 Possibility of hazardous reactions

No data available.

10.4 Conditions to avoid

No data available.

10.5 Incompatible materials

Strong acids/alkalis, strong oxidising/reducing agents.

10.6 Hazardous decomposition products

Under fire conditions, may decompose and emit toxic fumes.

Other decomposition products - no data available.

11.TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects

Acute toxicity

Classified based on available data. For more details, see section 2

Skin corrosion/irritation

Classified based on available data. For more details, see section 2

Serious eye damage/irritation

Classified based on available data. For more details, see section 2

Respiratory or skin sensitization

Classified based on available data. For more details, see section 2

Germ cell mutagenicity

Classified based on available data. For more details, see section 2

Carcinogenicity

IARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or

confirmed human carcinogen by IARC.

ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed

carcinogen by ACGIH.

NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed

carcinogen by NTP.

OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed

carcinogen by OSHA.

Reproductive toxicity

Page 4 of 6 www.MedChemExpress.com

Page 5

Classified based on available data. For more details, see section 2

Specific target organ toxicity - single exposure

Classified based on available data. For more details, see section 2

Specific target organ toxicity - repeated exposure

Classified based on available data. For more details, see section 2

Aspiration hazard

Classified based on available data. For more details, see section 2

Additional information

This information is based on our current knowledge. However the chemical, physical, and toxicological properties have not been

completely investigated.

12. ECOLOGICAL INFORMATION

12.1 Toxicity

No data available.

12.2 Persistence and degradability

No data available.

12.3 Bioaccumlative potential

No data available.

12.4 Mobility in soil

No data available.

12.5 Results of PBT and vPvB assessment

PBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.

12.6 Other adverse effects

No data available.

13. DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods

Product

Dispose substance in accordance with prevailing country, federal, state and local regulations.

Contaminated packaging

Conduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.

14. TRANSPORT INFORMATION

DOT (US)

Proper shipping name: Not dangerous goods

UN number: -

Class: -

Packing group: -

IMDG

Proper shipping name: Not dangerous goods

Page 5 of 6 www.MedChemExpress.com

Page 6

UN number: -

Class: -

Packing group: -

IATA

Proper shipping name: Not dangerous goods

UN number: -

Class: -

Packing group: -

15. REGULATORY INFORMATION

SARA 302 Components:

No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.

SARA 313 Components:

This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis)

reporting levels established by SARA Title III, Section 313.

SARA 311/312 Hazards:

No SARA Hazards.

Massachusetts Right To Know Components:

No components are subject to the Massachusetts Right to Know Act.

Pennsylvania Right To Know Components:

No components are subject to the Pennsylvania Right to Know Act.

New Jersey Right To Know Components:

No components are subject to the New Jersey Right to Know Act.

California Prop. 65 Components:

This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive

harm.

16. OTHER INFORMATION

Copyright 2025 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to

be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must

only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of

safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from

handling or from contact with this product.

Caution: Product has not been fully validated for medical applications. For research use only.

Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@MedChemExpress.com

Address: 1 Deer Park Dr, Suite F, Monmouth Junction, NJ 08852, USA

Page 6 of 6 www.MedChemExpress.com